ANTICANCER COMPOSITIONS
#602METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS
#603COMPOSITIONS AND METHODS FOR TREATING SEVERE CONSTIPATION
#604COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO
#605METHODS AND COMPOSITIONS FOR TREATING GORLIN SYNDROME
#606THERAPEUTIC AGENT FOR CANCER OF PATIENT WITH DECREASE IN RB1 FUNCTION USING MYT1 INHIBITOR AND CHEMOTHERAPEUTIC AGENT IN COMBINATION, AND TREATMENT METHOD THEREOF
#607PROTEASE INHIBITORS AND METHODS OF USE
#608Therapeutic Compounds
#609MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE
#610SUBSTITUTED DIAZASPIROALKANES AS ANDROGEN RECEPTOR MODULATORS
#611METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19
#612COMBINATION THERAPY FOR TREATMENT OF LIVER DISEASES
#613NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR
#614Methods of Treating Fabry Disease in Pediatric Patients
#615New Centrally-Active Ghrelin Agonist and Medical Uses Thereof
#616METHOD OF TREATING COGNITIVE DEFICITS ASSOCIATED WITH SCHIZOPHRENIA
#617NEUTROPHIL EXOCYTOSIS INHIBITORS
#618ISOQUINOLINE AND PYRIDINE BASED CXCR4 ANTAGONISTS
#619INHIBITOR COMPOUNDS
#620RAMIPRIL SOLUTION FOR ORAL DOSAGE
#621METHODS FOR TREATING ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
#622NALTREXONE FOR IMPROVING THE EFFECTIVENESS OF 5-HT RECEPTOR SUBTYPE 2A, 2B or 2C AGONISTS
#623READY-TO-ADMINISTER HYDROMORPHONE FORMULATIONS
#624THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE
#625Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor...
#626GASTRO-RESISTANT HIGH-STRENGTH FORMULATION CONTAINING POSACONAZOLE
#627NOVEL AZAINDOLE DERIVATIVES AS ANTIVIRAL AGENTS
#628COMBINATION THERAPY WITH AN LXR AGONIST AND AN INHIBITOR COMPOUND
#629FORMULATION CONTAINING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE (as amended)
#630Treatment of Symptoms Associated with Myeloproliferative Neoplasms
#631SALT AND CRYSTAL FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR
#632(1H-PYRROLO[2,3-B]PYRIDIN-1-YL)PYRIMIDIN-2-YL-AMINO-PHENYL-ACRYLAMIDE INHIBITORS OF EGFR FOR USE IN THE TREATMENT OF BRAIN TUMORS
#633COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS
#634METHODS OF TREATING CANCERS
#635METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE
#636METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE
#637COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY
#638COMBINATION THERAPY COMPRISING JAK PATHWAY INHIBITOR AND ROCK INHIBITOR
#639NAMPT ACTIVATORS FOR TREATING METABOLIC AND NEUROLOGICAL DISORDERS
#640COMPOUND AND METHOD FOR TREATING CHEMOTHERAPY-RELATED GASTROINTESTINAL SIDE EFFECTS
#641GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR THE TREATMENT OF ENDOMETRIOSIS
#642COMBINATION THERAPIES
#643TREATMENT OF LIVER DISORDERS WITH A THR-ß AGONIST
#644MEDICAMENT FOR PREVENTING AND/OR TREATING DRY EYE
#645COMBINATION THERAPY FOR TREATING CANCER
#646COMBINATION THERAPY FOR TREATING CANCER
#647PHARMACEUTICAL COMPOSITION, PREPARATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#648CRYSTALLINE COMPOSITION OF TILDACERFONT AND METHODS OF USE AND PREPARATION THEREOF
#649SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
#650STAT DEGRADERS AND USES THEREOF
#651CARNITINE-PALMITOYL-TRANSFERASE-1 (CPT-1) INHIBITORS FOR USE IN A METHOD OF PREVENTING OR TREATING SEPSIS IN A MAMMALIAN SUBJECT
#652BZD-1 AS A CHEMOSENSITIZER OF CANCER
#653INTRAVENOUS ISTAROXIME FOR THE TREATMENT OF ACUTE HEART FAILURE
#654PHARMACEUTICAL KIT FOR PARENTERAL CO-ADMINISTRATION
#655AQUEOUS, ROOM-TEMPERATURE STABLE ROCURONIUM COMPOSITION
#656MICROBIAL-TRIGGERED ORAL INTESTINAL DRUG DELIVERY FORMULATION AND METHOD OF PREPARATION THEREOF
#657WITHAFERIN A AND IMMUNE CHECKPOINT BLOCKER COMBINATION THERAPIES
#658COMPOSITIONS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF ALZHEIMER'S DISEASE
#659Use of Cannabidiol to Improve Rehabilitation in Lung Cancer
#660STABILIZED COMPOSITIONS COMPRISING CANNABIDIOL
#661COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS
#662Methods and Compositions for Treating Human Disorders Using D-Cycloserine and a Psychedelic Agent
#663Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene
#664METHODS OF SELECTIVELY MODULATING GASTROINTESTINAL MICROBIAL GROWTH
#665ANTITUMOR PHARMACEUTICAL COMPOSITION COMPRISING AZVUDINE AND CHEMOTHERAPEUTIC AGENT
#666TREATMENT REGIMENS
#667METHOD FOR PREVENTING OR TREATING DENTIN-DENTAL PULP DISEASE OR PERIODONTAL DISEASE, CONTAINING LPAR2 INHIBITOR
#668NEW THERAPEUTIC USE OF TYPE 2 IODOTHYRONINE DEIODINASE (D2) INHIBITORS
#669ASSOCIATION OF MOLECULAR OXYGEN AND HYALURONIC ACID OR ITS SALTS FOR USE IN THE TREATMENT OF SYMPTOMATOLOGY ASSOCIATED WITH VULVAR VESTIBULITIS
#670HEPARAN SULFATE MIMETICS TO IMPROVE GLUCOSE CLEARANCE
#671PHARMACEUTICAL COMPOSITION
#672SYSTEM FOR TRANSPORTING AND DELIVERING OF NITRIC OXIDE
#673TCM THROAT TEA METHOD AND COMPOSITION
#674Materials and Methods for Prevention and Treatment of Diarrhea and Inflammation in the Gastrointestinal Tract
#675COMPOSITION FOR TREATING BONE LOSS
#676COMPOSITION FOR TREATING BONE LOSS
#677COMPOSITION FOR TREATING BONE LOSS
#678ANGIOGENESIS MATERIAL, BONE-REGENERATION-PROMOTING MATERIAL, METHOD FOR PRODUCING ANGIOGENESIS MATERIAL, AND METHOD FOR PRODUCING BONE-REGENERATION-PROMOTING MATERIAL
#679COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#680MATERIALS AND METHODS FOR BINDING SIGLEC-3/CD33
#681TCR-T CELL FOR KILLING TUMORS, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#682ARMED NK CELLS FOR UNIVERSAL CELL THERAPY
#683COMBINATIONS OF SMALL MOLECULE DRUG CONJUGATE AND CAR-EXPRESSING CYTOTOXIC LYMPHOCYTES AND METHODS OF TREATING CANCER USING THE SAME
#684CLAUDIN18.2 CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#6853-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE THEREOF
#686PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING SARS-COV-2 ANTIGENS AND METHODS OF USE
#687DKK1/HLA-A2 BINDING MOLECULES AND METHODS OF THEIR USE
#688Methods of Treating T Cell Exhaustion by Inhibiting or Modulating T Cell Receptor Signaling
#689Immune Cell Fusion (ICF) and Uses Thereof
#690BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20
#691TISSUE REPAIR
#692Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant
#693DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT
#694DOPAMINERGIC NEURON PROGENITOR CELLS OR CELL DERIVATIVES THEREOF OBTAINED FROM LINEAGE RESTRICTED PLURIPOTENT STEM CELLS
#695FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
#696FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
#697EXOSOMES DERIVED FROM IMMORTALIZED MESENCHYMAL STROMAL CELLS (hMSCs) FOR USE AS A MEDICAMENT
#698PLACENTAL CELL TREATMENT FOR CRITICAL LIMB ISCHEMIA PATIENT SUBPOPULATIONS
#699Bee Product Extracts, Methods of Production, and Uses Thereof
#700METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#701Programmable Nanoencapsulation for Delivery of Probiotics in Vivo
#702USE OF AKKERMANSIA IN THE TREATMENT OF ORAL DISEASES
#703Methods and Compositions for Changing Metabolite Levels in a Subject
#704AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF DIAPER RASH, ATHLETE’S FOOT, CONTACT DERMATITIS, PERSPIRATION, AND BODY ODOR
#705IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT
#706PRODUCTION OF A PROBIOTIC COMPOSITION
#707MICROBIOME RELATED IMMUNOTHERAPIES
#708METHODS AND COMPOSITIONS FOR PREDICTING CANCER SURVIVAL AND CAR T CELL TOXICITY
#709COMPOSITIONS AND METHODS FOR TREATING BIOFILMS, INFECTIONS AND PERIODONTITIS
#710PROBIOTIC COMPOSITION FOR THE TREATMENT OF INCREASED INTESTINAL PERMEABILITY
#711LACTOBACILLUS PLANTARUM GB104 STRAIN AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CANCER
#712COMPOSITIONS AND METHODS USING A COMBINATION OF AT LEAST ONE FIBER AND AT LEAST ONE PROBIOTIC TO IMPROVE MICROBIOME RESILIENCE
#713Compositions For and Methods of Promoting Respiratory Health
#714IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS
#715PHYSIOLOGICALLY ACCEPTABLE YEAST COMPOSITIONS AND USES THEREOF
#716PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES
#717CHRYSANTHEMUM ZAWADSKII EXTRACT AND PREPARING METHOD THEREOF
#718EFFICIENT LIPID DELIVERY TO HUMAN TEAR FILM USING A SALT-SENSITIVE EMULSION SYSTEM
#719TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL
#720COMPOSITION FOR ALLEVIATING, TREATING, OR PREVENTING MUSCULAR DISEASES, OR IMPROVING MUSCULAR FUNCTIONS, CONTAINING KOREAN MINT EXTRACT OR TILIANIN AS ACTIVE INGREDIENT
#721COMPOSITION FOR IMPROVING COGNITIVE ABILITY OR MEMORY ABILITY, CONTAINING FERMENTED PERILLA FRUTESCENS EXTRACT, AND USE THEREOF
#722NOVEL THERAPEUTIC COMPOSITION BASED ON ESSENTIAL OILS AT LOW DOSES
#723PROCESS FOR PURIFICATION OF MITRAGYNINE
#724COMPOSITIONS
#725ANTI-CANCER COMPOSITION
#726VISTA AGONISTS AND RELATED COMPOSITIONS AND METHODS
#727PEPTIDE HAVING ANTICANCER ACTIVITY, AND USE THEREOF
#728Reagents, Pharmaceutical Formulations, and Methods for Treating and Preventing Viral Infection
#729PHARMACEUTICAL COMPOSITIONS COMPRISING TEIXOBACTIN
#730METHODS AND COMPOSITIONS FOR TREATING MICROBIAL INFLAMMATION
#731RECOMBINANT POLYPEPTIDES AND COMBINATIONS FOR USE IN THE TREATMENT OF CANCER
#732REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V
#733IMMUNE CHECKPOINT INHIBITOR COMBINATIONS
#734Methods for Enhancing Immune Checkpoint Inhibitor Therapy
#735METHODS OF TREATING METABOLIC DISORDERS ASSOCIATED WITH LIPODYSTROPHIES AND DEFECTS IN INSULIN PRODUCTION OR SIGNALING
#736METHODS OF TREATING INFLAMMATORY BOWEL DISEASE
#737TREATMENT OF INFLAMMATORY CONDITIONS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN
#738HEPCIDIN MIMETICS FOR TREATMENT OF HEREDITARY HEMOCHROMATOSIS
#739THERAPEUTIC USE OF COMBINATION INCLUDING TRIPLE AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS
#740USE OF MAZDUTIDE
#741PHARMACEUTICAL COMPOSITIONS COMPRISING GLP-1R AGONISTS
#742STABLE LIQUID FORMULATIONS OF GLUCAGON-LIKE PEPTIDE 1 OR ANALOGUES THEREOF
#743FACTOR IX SUBCUTANEOUS ADMINISTRATION WITH ENHANCED SAFETY
#744Chimeric endolysin polypeptide, cluster 3b
#745METHOD FOR PROPHYLAXIS AND/OR TREATMENT OF ErbB2 POSITIVE CANCERS
#746Universal mRNA Vaccine to Treat Dementia-Causing Neurodegenerative Disorders
#747Antigenic Peptides For Prevention And Treatment Of Cancer
#748COMBINATION USE OF WT1 ANTIGEN PEPTIDE AND IMMUNOMODULATOR
#749BACILLUS CALMETTE-GUERIN (BCG) AND ANTIGEN PRESENTING CELLS FOR TREATMENT OF BLADDER CANCER
#750VACCINE METHOD AND COMPOSITION FOR BACTERIAL DISEASES IN INVERTEBRATES
#751MULTIPLE FUNCTIONALIZED noMV CONJUGATES
#752VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION
#753EBOLAVIRUS AND MARBURGVIRUS VACCINES
#754DEOPTIMIZED YELLOW FEVER VIRUS AND METHODS AND USES THEREOF
#755METHODS OF TREATMENT OF HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)
#756IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#757MULTIVALENT INFLUENZA NANOPARTICLE VACCINES
#758INACTIVATED SARS-COV-2 VIRUS VACCINE
#759REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE
#760RECOMBINANT MEASLES VIRUS
#761CORONAVIRUS GLYCOSYLATION VARIANT VACCINES
#762Therapeutic Viral Vaccine
#763PORCINE BIVALENT SUBUNIT VACCINE COMPOSITION IN A SINGLE DOSE
#764AMPHIPHILIC IMIQUIMOD-GRAFTED LAURYL GAMMA-POLYGLUTAMATE AND USE THEREOF
#765NOVEL METHODS FOR MANUFACTURING AN ADJUVANT
#766BOVINE COLOSTRUM DERIVED ANTIBODIES AND USES THEREOF
#767COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A THERAPEUTIC AGENT TARGETING COMPLEMENT C5
#768LSP1-DEFICIENT T CELL
#769PHARMACEUTICAL COMPOSITION CONTAINING REGULATORY T CELLS AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES
#770ENGINEERED CELLS FOR THERAPY
#771MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF
#772Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems
#773D2C7 EGFR AND EGFR VIII BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND METHODS OF MAKING AND USING SAME
#774POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING
#775CONTACT LENS FOR PHOTODYNAMIC INACTIVATION OF GERMS, PRODUCT AND METHOD OF TREATING FUNGAL KERATITIS BY APPLYING THE SAME
#776Conjugates And Conjugating Reagents
#777BRANCHED OLIGONUCLEOTIDES
#778USE OF ST-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT
#779IONIC LIQUID COMPOSITIONS
#780P-SELECTIN INHIBITORS AND USES THEREOF
#781QUATERNIZED NICOTINAMIDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIBITOR CONJUGATES
#782CARBOHYDRATE CONJUGATES FOR THE DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES
#783CARBOHYDRATE DERIVATIVES AND KITS FOR CELL SURFACE LABELING
#784PROTEOLYSIS TARGETING CHIMERAS AND METHODS OF USE THEREOF
#785KRAS INHIBITOR CONJUGATES
#786SHP2 inhibitor, pharmaceutical composition containing the same and application thereof
#787POLYOXAZOLINE-DRUG CONJUGATES WITH NOVEL PHARMACOKINETIC PROPERTIES
#788BRAIN PERMEABLE MULTIFUNCTIONAL SYSTEM AND USES THEREOF
#789METHODS FOR USING NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS IN THE TREATMENT OF A NEUROLOGICAL CONDITION
#790GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#791LOCALIZED DELIVERY OF ANTI-FUGETACTIC AGENT FOR TREATMENT OF CANCER
#792ANTI-HER3 ANTIBODY, ANTIBODY DRUG CONJUGATE CONTAINING THE SAME, AND USE THEREOF
#793ANTI-EGFRvIII ANTIBODY DRUG CONJUGATES AND USES THEREOF
#794NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF
#795MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES
#796LINKER FOR ANTIBODY-DRUG CONJUGATE
#797HIGHLY STABLE TARGETED LINKER-DRUG CONJUGATE
#798BRAIN-TARGETED ANTIBODY NANOPARTICLE FOR NEURODEGENERATIVE DISEASES THERAPY
#799THERAPEUTIC-AGENT-RELEASING HYDROGELS AND PRECURSORS THEREOF
#800PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING LIPID-PHOTOTHERMAL NANOPARTICLE HAVING ANTIBODY BOUND TO SURFACE
#801CATIONIC LIPIDS AND COMPOSITIONS THEREOF
#802NANOPARTICLES COMPRISING PEPTIDES INCLUDING AN N-TERMINAL LINKER
#803NUCLEIC ACID CONSTRUCT FOR AIDS GENE THERAPY
#804METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA
#805METHODS OF TREATING MITOCHONDRIAL DISORDERS
#806Composition Comprising Trim31 and Rhbdf2 for Treatment of NAFLD/NASH
#807Optimized RPE65 Promoter and Coding Sequences
#808NEUROPROTECTION GENE THERAPY
#809DNA COMPOSITIONS COMPRISING MODIFIED CYTOSINE
#810RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF
#811IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA)
#812HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS
#813RADIOLABELED COMPOUND AND USE THEREOF
#814CXCR4-TARGETED DIAGNOSTIC AND THERAPEUTIC AGENTS WITH REDUCED SPECIES SELECTIVITY
#815THERAPEUTIC CONJUGATES
#816HYPOCHLOROUS ACID ULTRASOUND PROBE DISINFECTION CHAMBER
#817Sanitizing Appliance
#818ULTRAVIOLET DISINFECTING APPARATUS
#819System And Method For Automating Verification Of Medical Instrument Sterilization Compatibility And Sterilization Cycle Selection
#820AIR SANITATION DEVICE BY EMISSION OF A BARRIER OF ULTRAVIOLET RADIATION IN AN AIR FLOW
#821HEMOSTATIC SPONGE
#822MULTILAYER DEVICE FOR SUPPLYING NITRIC OXIDE
#823COMPOSITIONS AND METHODS FOR TREATING WOUNDS
#824SILVER NANOPLATE COMPOSITIONS AND METHODS
#825Shape memory material with chelating system and preparation method thereof
#826BONE-REGENERATION-PROMOTING MATERIAL, AND METHOD FOR PRODUCING BONE-REGENERATION-PROMOTING MATERIAL
#827COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT
#828SKELETAL STRUCTURE FOR ARTIFICIAL PINNA AND ARTIFICIAL CARTILAGINOUS TISSUE, AND ARTIFICIAL PINNA USING SAME
#829DIAPHRAGM FOR A BREAST PUMP AND A BREAST PUMP HAVING THE DIAPHRAGM
#830Intelligent Adjustment of Computing Device Operations
#831SYSTEM AND METHOD FOR COLLECTING PLASMA
#832Device for Removal of Implants and Associated Method of Use
#833SYSTEM AND METHOD FOR TREATING A GASTROINTESTINAL TRACT OF A SUBJECT
#834NEGATIVE PRESSURE WOUND THERAPY DEVICES
#835ELECTRONIC AUTOMATICALLY ADJUSTING BIDET COMMODE WITH ARTIFICIAL INTELLIGENCE AND SPECTROSCOPY SOFTWARE
#836LATCH FOR CAPTURING AND SECURING A CASSETTE TO A MEDICAL DEVICE
#837SYSTEM AND METHOD OF MONITORING AND MANAGING A REMOTE INFUSION REGIMEN
#838A SYSTEM FOR THE CONTROLLED ADMINISTRATION OF A SUBSTANCE WITH AN IMPLANTABLE INFUSION DEVICE PROVIDED WITH AN IMPROVED DOCKING GROUP FOR RELIABLY DOCKING AN INGESTIBLE SUBSTANCE CARRIER
#839DRUG DELIVERY DEVICE
#840PIEZO-ACTUATED DRIVE UNIT FOR SYRINGE PUMP
#841AGENT ADMINISTERING MEDICAL DEVICE
#842INFUSION SET AND INSERTER ASSEMBLY SYSTEMS AND METHODS
#843LIQUID MEDICINE INJECTION DEVICE
#844INITIAL TOTAL DAILY INSULIN SETTING FOR USER ONBOARDING
#845DETERMINATION OF DOSES OF INSULIN AND RELATED SYSTEMS, METHODS, AND DEVICES
#846METHOD TO IMPROVE SAFETY MONITORING IN TYPE-1 DIABETIC PATIENTS BY DETECTING IN REAL-TIME FAILURES OF THE GLUCOSE
#847ARTICLES, SYSTEMS, AND METHODS FOR THE INJECTION OF VISCOUS FLUIDS
#848Autoinjector
#849Autoinjector
#850ASSEMBLABLE COMPACT SYRINGE WITH SIDE MOUNTED PLUNGER ROD
#851INSULIN INJECTION ASSISTANCE SYSTEMS, METHODS, AND DEVICES
#852Data Logging Device for Monitoring Use of an Injection Device
#853Safety Clip for Medical Injection Device
#854SYSTEMS AND METHODS FOR MIXING SYRINGE VALVE ASSEMBLIES
#855SPRAY DEVICE AND AIR TREATMENT DEVICE
#856VAPORIZER CARTRIDGE AND INHALER COMPRISING SUCH A VAPORIZER CARTRIDGE
#857MULTIFUNCTIONAL WEARING DEVICE
#858CLOSED INTUBATION SYSTEMS HAVING IMPROVED AIRWAY ACCESS FOR EXAMINATION DEVICES
#859TRACHEAL TUBE ASSEMBLY
#860LARYNGEAL TUBE
#861SYSTEMS AND METHODS FOR ASSISTING PATIENT AIRWAY MANAGEMENT
#862RESPIRATORY INTERFACE ASSEMBLY
#863IMPROVED BYPASS CONDUIT HAVING A PORT
#864ANESTHESIA MACHINE, RESPIRATORY SUPPORT DEVICE, AND VENTILATION CONTROL METHOD
#865HEATING ARRANGEMENTS FOR HUMIDIFICATION SYSTEMS
#866TUB FOR HUMIDIFIER
#867SYSTEM AND METHOD FOR SOOTHING INFANTS
#868CATHETER AND METHOD FOR PREPARING CATHETER TRANSITION STRUCTURE
#869GUIDE EXTENSION CATHETER
#870Devices and Methods for Fluid Transfer Through a Placed Peripheral Intravenous Catheter
#871SUBCUTANEOUS TUNNELING CATHETER FOR PERITONEAL ACCESS
#872MULTI-LUMEN CENTRAL LINE
#873SAFETY CATHETER ASSEMBLY
#874ANGIOPLASTY DEVICE
#875PARANASAL SINUS FLUID ACCESS IMPLANTATION TOOLS, ASSEMBLIES, KITS AND METHODS
#876SYSTEMS, CATHETERS, AND METHODS FOR TREATING ALONG THE CENTRAL NERVOUS SYSTEM
#877DRUG DELIVERY DEVICE AND METHODS FOR USING SAME
#878CAPSULE ADMINISTERING ASSEMBLY
#879Systems, Devices and Methods for Intradermal or Subdermal Fluid Delivery
#880HYDROGEL MICRONEEDLE PATCH BASED ON THREE-DIMENSIONAL FRAMEWORK STRUCTURE, AND PREPARATION METHOD AND APPLICATION THEREOF
#881Port with Detachable Stem
#882TOOLS AND METHODS FOR DIRECTLY ACCESSING THE CAROTID ARTERY
#883FUNCTIONAL ADAPTER FOR DIALYSIS MACHINE
#884MEDICAL CONNECTOR
#885INTRAVENOUS PRIMING CAP
#886Pinch Clamp Devices, Methods, and Systems
#887BLOOD PUMP
#888INTRAVASCULAR BLOOD PUMP
#889IMPLANTABLE HEART PUMP SYSTEMS INCLUDING AN IMPROVED APICAL CONNECTOR AND/OR GRAFT CONNECTOR
#890THERAPEUTIC ELECTRICAL MUSCLE STIMULATION APPARATUS AND METHOD OF IMPROVING MEDICAL PROCEDURE OUTCOMES
#891THERAPEUTIC ELECTRICAL MUSCLE STIMULATION APPARATUS AND METHOD OF TREATMENT
#892ELICITING SWALLOWING USING ELECTRICAL STIMULATION APPLIED VIA SURFACE ELECTRODES
#893SYSTEMS AND METHODS FOR MANAGED TRAINING AND REHABILITATION VIA ELECTRICAL STIMULATION
#894Current Generation Architecture for an Implantable Medical Device
#895MONOLITHIC PERICARDIAL PACEMAKERS
#896Wrist-Worn Independent 3-Point Acupuncture Stimulator
#897Wrist-Worn Independent 3-Point Acupuncture Stimulator
#898TREATMENT OF OVERACTIVE BLADDER WITH PHASE-CONTINGENT PUDENDAL NERVE STIMULATION
#899MODULAR IMPLANT DELIVERY AND POSITIONING SYSTEM
#900NEUROSTIMULATOR TO AID IN RECOVERY FROM STROKE OR OTHER LIMITATIONS IN HUMAN FUNCTION